Medifoxamine

DB13219ApprovedSmall molecule

Medifoxamine was marketed as an atypical antidepressant, with anxiolyitc properties in France, Spain, and Morrocco in the 1990s but was later withdrawn from the market due to it causing cases...

Chemical structure of Medifoxamine
Formula / weight
C16H19NO2 · 257.333 g/mol (avg)

Resolves to

Compound
UNIIKWU7C2A1NTCAS32359-34-5ChEMBLCHEMBL85231ChEBI135061
Clinical / RWD
RxNorm29434ATCN06AX13
Structure
InChIKeyQNMGHBMGNRQPNL-UHFFFAOYSA-NSMILESCN(C)CC(OC1=CC=CC=C1)OC1=CC=CC=C1

What you can answer from here — as of February 21, 2021

679Drug interactionsStructured to mechanism, not free text
Sign in
1ATC codeIncluding every combination product, plus 5 drug categories
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Medifoxamine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In